enable these patients to fulfil their reproductive aspirations. Recently a large retrospective study in the USA showed that Rokitansky syndrome is a developmental defect charactercongenital absence of the uterus and vagina is not commonly ized by agenesis of the uterus and vagina but normal transmitted as a dominant genetic trait (Petroza et al., 1997 ) gonads and secondary sexual characters. It is not commonly transmitted as a dominant genetic trait. Surrogacy, which is legally and ethically accepted in the UK and other
Materials and methods countries, has made it possible for the patients with this
All gestational surrogacy cycles that took place in a private clinic in syndrome to have their own genetic children. Six patients London, UK from January 1993 to November l996 were reviewed.
with Rokitansky syndrome underwent 11 ovarian stimulaSix patients with Rokitansky syndrome had 11 ovarian stimulation tion cycles that resulted in 11 fresh and three frozen embryo cycles that resulted in 11 fresh embryo transfer and three frozen transfer procedures into six prospective surrogate mothers.
embryo replacement procedures into six prospective surrogate Both commissioning and surrogate couples were properly mothers. The case notes were retrieved and reviewed in detail.
screened and counselled and their treatment was approved
All patients attended the clinic with their partners for an initial consultation and subsequently recruited their own surrogate mother, by the clinic internal review committee (ethics committee).
either personally or through a charity agency. as a spectrum of Müllerian anomalies, including vaginal The mean age of the patients was 31.5 years (range 25-35) and agenesis with or without renal anomalies in genotypic and they were all in their first attempt at assisted conception. All six phenotypic female subjects with normal endocrine status patients completed at least one cycle of treatment (Table I) . Prior vaginoplasty had been carried out in two patients and four others had (Ghirardini and Popp, 1995) . There has not been any cause Rokitansky syndrome. A medical literature search gave us gonadotrophin injections were given for 12-16 days until the leading access to a few articles about Mayer-Rokitansky-Kuster-Hauser follicles were~20 mm in diameter. Oocyte retrieval was performed syndrome, particularly about its classification (Tarry et al., 36 h following an injection of 10 000 IU of human chorionic 1986; Strubble et al., 1993; Fedele et al., 1996) . Many of gonadotrophin. All prospective commissioning mothers had vaginal these papers have centred on the creation of a functional oocyte retrieval except one who required laparoscopic oocyte retrieval vagina, diagnosis and management of the sporadic cases as her ovaries were not accessible through the vagina. A natural cycle (Muram and Jones, 1994; Russ et al., 1997; Giatras et al., was used in one surrogate as she had previously experienced side-1998) and the recent advances in laparoscopic treatment effects with a gonadotrophin-releasing hormone analogue. She compared to laparotomy (Popp and Ghirardini, 1992; Giraldo abstained from sexual intercourse during the treatment cycle. All the Major et al., 1997) . Only a handful of the papers other surrogates underwent down-regulation with leuprolide acetate injection 3.75 mg. When the commissioning mother started her reviewed the reproductive potential of these patients (Egarter gonadotrophin injections the surrogate mother started oral oestradiol and Huber, 1988; Yovich and Hoffman, 1988; Batzer et al., and Hoffman, 1988; Utian et al., 1989) . A large retrospective successful embryo transfer. study was presented in 1997 (Petroza et al., 1997) with many more treatment cycles for patients with Rokitansky syndrome Results attempted to determine if there was an inheritance pattern of the syndrome through a questionnaire distributed to all the The six patients completed 11 oocyte retrieval procedures (average of 1.8 per patient). A total of 161 eggs was retrieved.
centres performing surrogacy treatment in the USA. A total of 162 IVF/surrogacy treatment cycles performed for 58 The mean number of eggs collected per cycle was 14.6 (range 2-49). The fertilization rate was 68.9%. Either two or three patients with congenital agenesis of the uterus and vagina was reviewed. The treatment resulted in 34 live births (17 female embryos were transferred into the surrogate in each treatment cycle (average 2.7). A total of 67 embryos was cryopreserved and 17 male). One male child was diagnosed with an nonspecific middle ear defect and hearing loss. They concluded (average of 6.1 embryos per cycle). A total of 11 fresh and three frozen embryo transfer procedures took place (18 embryos that congenital absence of the uterus and vagina was not inherited commonly in a dominant fashion. Another group were thawed for the three frozen embryo replacement cycles) of its kind in the UK, which confirmed the fact that women population. All our patients had been diagnosed and treated in their adolescent years and had knowledge of their inability to conceive.
In future, we speculate that these patients will seek advice much earlier as IVF technology will be more widespread and more accessible. Detailed information and counselling in young adulthood will play an important role. In this retrospective analysis we did not discuss legal issues concerning surrogacy and related matters in detail. We believe that patients with Rokitansky syndrome should be informed and supported, morally and financially, so they are able to have a family using their own genetic gametes before their reproductive age is over.
